AGARWALEYE / Q1-FY27 / risks

Keep the risk register visible.

Dr. Agarwal's Health Care · Material risks, their source context, and severity in the latest available quarter.

Research layer active

ConCallIQ research layer

Signal, with the source still visible.

Use the controls below to narrow the view, then follow the evidence into the next layer of context.

PositiveQ1-FY27 · source date pendingBack to quarter ↗

Risk intelligence

Material risks this quarter

Significant drag from new facility losses during ramp-up phase

New facilities (FY26 and FY27 vintages) are collectively running at ~20 crores loss level. These centers take ~3 years to mature, creating sustained drag on profitability as expansion accelerates.

medium

North region facilities significantly less productive than South

Delhi NCR and other northern facilities are far from mature state; surgeries per center in North are not close to South mature facility levels despite 50.5% growth rate, indicating long ramp-up runway required.

medium

Average realization growth trajectory uncertain

Premium ARPU has grown from ~28,500 to ~42,000 over four years with ~10% value growth. Analyst questioned whether 10% ARPU growth is sustainable given base effect, and management could not provide specific guidance on trajectory.

low

Merger execution and integration timeline

Management confirmed mid-November expected closure but described being 'in the process of closing some of the final items,' suggesting some execution uncertainty around the merger completion.

medium